Lionel F. Conacher
CIK 1417326 · Interim CEO · last filed 2026-10-14
Lionel F. Conacher is an Interim CEO who has filed 54 SEC Form 4 insider transactions across 3 companies since 2008. The most recent filing shows the insider was granted $15.0K of DXLG on Oct 14, 2026. Across all open-market trades the lifetime net is +$300.9K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $247.4K across reported positions. 16 SEC filings were submitted jointly with Thomas Weisel Partners Group, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
TWPG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
555 TURNPIKE STREET
CANTON, MA 02021
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DXLG | Interim CEO | 499,843 | $0.49 | $247.4K | $165.2K | 28 | 2026-10-14 |
| SRx Health Solutions, Inc. (BTTR) Delisted | Interim CEO | 37,232 | $2.12 | $78.9K | $265.9K | 10 | 2024-12-26 |
| Thomas Weisel Partners Group, Inc. (TWPG) Delisted | President and COO | 639,827 | — | — | -$130.2K | 15 | 2010-03-10 |
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-10-14 | DXLG | Grant (A) | +38,167 | $15.0K | EDGAR |
| 2026-09-15 | DXLG | Grant (A) | +23,437 | $15.0K | EDGAR |
| 2026-08-14 | DXLG | Grant (A) | +25,720 | $15.0K | EDGAR |
| 2026-08-05 | DXLG | Grant (A) | +3,951 | $2.2K | EDGAR |
| 2026-05-06 | DXLG | Grant (A) | +32,608 | $20.2K | EDGAR |
| 2026-02-04 | DXLG | Grant (A) | +29,648 | $20.2K | EDGAR |
| 2025-12-03 | SRXH | Notice (144) | −37,007 | -$14.6K | EDGAR |
| 2025-11-05 | DXLG | Grant (A) | +20,266 | $20.2K | EDGAR |
| 2025-05-07 | DXLG | Grant (A) | +17,307 | $20.2K | EDGAR |
| 2024-12-26 | SRx Health Solutions, Inc. (BTTR) Delisted | Mixed | +29,828 | $226.3K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.